Abacavir hypersensitivity: Is pre-prescription genotyping cost-effective?

Research output: Contribution to conferencePaper

Standard Standard

Abacavir hypersensitivity: Is pre-prescription genotyping cost-effective? / Hughes, D.; Hughes, D.A.
2003. Paper presented at Welsh Health Economics Group, Swansea, Wales, UK.

Research output: Contribution to conferencePaper

HarvardHarvard

Hughes, D & Hughes, DA 2003, 'Abacavir hypersensitivity: Is pre-prescription genotyping cost-effective?', Paper presented at Welsh Health Economics Group, Swansea, Wales, UK, 3/01/01.

APA

Hughes, D., & Hughes, D. A. (2003). Abacavir hypersensitivity: Is pre-prescription genotyping cost-effective?. Paper presented at Welsh Health Economics Group, Swansea, Wales, UK.

CBE

Hughes D, Hughes DA. 2003. Abacavir hypersensitivity: Is pre-prescription genotyping cost-effective?. Paper presented at Welsh Health Economics Group, Swansea, Wales, UK.

MLA

Hughes, D. and D.A. Hughes Abacavir hypersensitivity: Is pre-prescription genotyping cost-effective?. Welsh Health Economics Group, Swansea, Wales, UK, 03 Jan 0001, Paper, 2003.

VancouverVancouver

Hughes D, Hughes DA. Abacavir hypersensitivity: Is pre-prescription genotyping cost-effective?. 2003. Paper presented at Welsh Health Economics Group, Swansea, Wales, UK.

Author

Hughes, D. ; Hughes, D.A. / Abacavir hypersensitivity: Is pre-prescription genotyping cost-effective?. Paper presented at Welsh Health Economics Group, Swansea, Wales, UK.

RIS

TY - CONF

T1 - Abacavir hypersensitivity: Is pre-prescription genotyping cost-effective?

AU - Hughes, D.

AU - Hughes, D.A.

PY - 2003/5/1

Y1 - 2003/5/1

M3 - Paper

T2 - Welsh Health Economics Group, Swansea, Wales, UK

Y2 - 3 January 0001

ER -